MedTrace Logo

Supine Positioning for Graft Attachment After Descemet Membrane Endothelial Keratoplasty

NCT05399095 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-07-25

No results posted yet for this study

Summary

This randomized controlled trial evaluates the efficacy and safety of postoperative supine head positioning on graft attachment after Descemet membrane endothelial keratoplasty in patients with Fuchs' endothelial corneal dystrophy (FECD).

Conditions

  • Fuchs' Endothelial Dystrophy

Interventions

BEHAVIORAL

Supine positioning: 5 days

Supine positioning for 5 days after DMEK

BEHAVIORAL

Supine positioning: 1 days

Supine positioning for 1 days after DMEK

Sponsors & Collaborators

  • University Eye Hospital, Freiburg

    lead OTHER

Principal Investigators

  • Katrin Wacker, MD FEBO · University of Freiburg, Eye Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-23
Primary Completion
2023-05-23
Completion
2023-05-23

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05399095 on ClinicalTrials.gov